Danish TV worker tests negative for Ebola

Initial results were negative for an employee of TV2 who had reported a fever after returning from west Africa but Hvidore Hospital says additional testing may be needed.

Danish TV worker tests negative for Ebola
This marks the third patient who has tested negative for Ebola at Hvidore Hospital in the past five weeks. Photo: Hvidore Hospital
A patient who was checked in to Hvidore Hospital on Tuesday on the suspicion of having the Ebola virus has tested negative.
The hospital announced that the patient’s preliminary test results were negative, but said it might send a new blood sample to the Danish State Serum Institute on Wednesday in order to completely rule out an Ebola infection. 
“If the patient no longer has a fever [on Wednesday], there will be no need to take additional tests, but if the patient continues to have symptoms, we will retain our emergency preparedness,” hospital spokesman Torben Mogensen said in a statement. 
This marks the third time in five weeks that a patient has tested negative for Ebola at Hvidore Hospital, located just outside of Copenhagen. 
Broadcaster TV2 said that the patient was an employee with the company who had recently returned from west Africa. After coming down with a fever, the employee was admitted to Hvidore Hospital on Tuesday and held in isolation.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Ebola tests sold to Denmark recalled

The US Food and Drug Administration said that Ebola kits sent to Denmark and other countries could result in "life-threatening" false positives.

Ebola tests sold to Denmark recalled
Photo: Colourbox
US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.
"A recall has been issued for the LuSys Laboratories, Inc., Ebola Virus One-Step Test Kits because the FDA has not cleared or approved the kits for use or sale," said the Food and Drug Administration in a statement emailed to reporters on Thursday.
"The results obtained from these test kits have not demonstrated to be accurate and should not be used as in vitro diagnostic tests for Ebola infection."
The recall was initially issued in mid-March and applies to test kits exported to Denmark, Sierra Leone and Canada between October 2014 and January 2015.
The FDA did not say how many tests were sent out.
The recall is described as a Class I, "the most serious type of recall and involve(s) situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death," the FDA said.
"A false positive result may be life-threatening by potentially placing the patient in an isolation cohort with Ebola-infected patients."
Contacted by AFP, a company representative in San Diego said early trials have shown the test to be 86 percent accurate.
The problem with the FDA came down to a labeling error, he said. The equipment had not been properly labeled "for research purposes only."